MW 467 Da, Purity >98%. Glucocorticoid, induces monooxygenase activity in vivo. Alters the structure of tight junctions in epidermis. Smoothened hedgehog pathway receptor agonist. Anti-inflammatory, immunosuppressive and antimitotic agent. Active in vivo.
2700049B16Rik, 3110031N04Rik, AIS, ANDR_HUMAN, AR, AR8, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), BK channel, BK channel beta subunit, BK channel subunit beta-1, BK channel subunit beta-2, BK channel subunit beta-4, BKCA alpha, BKCA alpha subunit, BKTM, BKbeta, BKbeta1, BKbeta2, BKbeta4, CAPC, Calcium activated potassium channel beta 4 subunit, Calcium activated potassium channel subfamily M subunit beta 1, Calcium activated potassium channel subfamily M subunit beta 2, Calcium activated potassium channel subfamily M subunit beta 4, Calcium-activated potassium channel, Calcium-activated potassium channel subunit alpha-1, Calcium-activated potassium channel subunit beta, Calcium-activated potassium channel subunit beta-1, Calcium-activated potassium channel subunit beta-2, Calcium-activated potassium channel subunit beta-4, Charybdotoxin receptor subunit beta-1, Charybdotoxin receptor subunit beta-2, Charybdotoxin receptor subunit beta-4, Cytokeratin-associated protein in cancer, DHTR, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), Drosophila slowpoke like, GCCR, GCRST, GCR_HUMAN, GR, Glucocorticoid receptor, Grl1, HUMARA, HYSP1, Hbeta1, Hbeta2, Hbeta3, Hbeta4, K(VCA)alpha, K(VCA)beta, K(VCA)beta-1, K(VCA)beta-2, K(VCA)beta-4, KCMA1_HUMAN, KCMB1_HUMAN, KCMB2_HUMAN, KCMB4_HUMAN, KCNMA, KCNMA1, KCNMB 1, KCNMB 2, KCa1.1, KD, Kennedy disease (KD), LRC26_HUMAN, Large conductance Ca2+ activated K+ channel beta 1 subunit, Large conductance Ca2+ activated K+ channel beta2 subunit, Large conductance calcium activated potassium channel beta 2 subunit, Large conductance calcium dependent potassium ion channel beta 4 subunit, Leucine-rich repeat-containing protein 26, Lrrc26, MGC22431, MGC57945, Maxi K channel, Maxi K channel beta subunit, Maxi K channel subunit beta-1, Maxi K channel subunit beta-2, Maxi K channel subunit beta-4, Maxi Potassium channel alpha, MaxiK, MaxiK channel beta 2 subunit, NR3C3, NR3C4, Nuclear receptor subfamily 3 group C member 1, Nuclear receptor subfamily 3 group C member 3, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), PGR, PR, PRA, PRB, PRGR_HUMAN, Potassium large conductance calcium activated channel subfamily M beta member 1, Potassium large conductance calcium activated channel subfamily M beta member 2, Potassium large conductance calcium activated channel subfamily M beta member 4, Progesterone receptor, Progestin receptor form A, Progestin receptor form B, SAKCA, SBMA, SLO, SMAX1, Slo homolog, Slo-alpha, Slo-beta, Slo-beta-1, Slo-beta-2, Slo-beta-4, Slo1, Slowpoke homolog, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), TFM, Testicular Feminization (TFM), androgen receptor splice variant 4b, bA350O14.10, cytokeratin-associated protein, glucocorticoid nuclear receptor variant 1, hSlo, hslo beta, nr3c1, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), subfamily M subunit alpha-1, subfamily M subunit beta-1, subfamily M subunit beta-2, subfamily M subunit beta-4
MW 467 Da, Purity >98%. Glucocorticoid, induces monooxygenase activity in vivo. Alters the structure of tight junctions in epidermis. Smoothened hedgehog pathway receptor agonist. Anti-inflammatory, immunosuppressive and antimitotic agent. Active in vivo.
Glucocorticoid, induces monooxygenase activity in vivo. Alters the structure of tight junctions in epidermis. Smoothened hedgehog pathway receptor agonist. Anti-inflammatory, immunosuppressive and antimitotic agent. Active in vivo.
The targets Glucocorticoid Receptor Progesterone Receptor Maxi Potassium channel alpha (SLO) Maxi Potassium channel beta (KCNMB1) Androgen Receptor KCNMB4 KCNMB2 and LRRC26 perform distinct mechanical functions in cells. The Glucocorticoid Receptor also known as NR3C1 acts as a transcription factor and is found in cytoplasm. It is about 97 kDa in weight and expressed in many tissues including kidney brain and liver. The Progesterone Receptor or PGR modulates gene expression and is widely expressed in reproductive tissues. The Maxi Potassium channels also known as BK channels consist of alpha and beta subunits like SLO and KCNMB1 KCNMB2 KCNMB4 which contribute to membrane potential regulation and are primarily located in the nervous system and muscles. LRRC26 associated with BK channels acts as an auxiliary subunit to modulate channel activity.
These targets play integral roles in various physiological processes. The Glucocorticoid Receptor mediates the effects of stress by regulating genes that control metabolism and immune responses. Maxi Potassium channels formed by combinations of SLO and KCNMB proteins regulate potassium ion flow to maintain cellular excitability and vascular tone. The Androgen Receptor influences male sexual development and bone density by controlling the expression of androgen-responsive genes. Together these targets often participate in complexes that integrate signals across cells modulating tissue-specific responses to hormones and external stimuli.
Each target protein fits into key biological signaling cascades that maintain homeostasis. The Glucocorticoid Receptor and Androgen Receptor are parts of the steroid hormone signaling pathways influencing genes involved in metabolism inflammation and cell growth. Maxi Potassium channels including their alpha and beta subunits are involved in the calcium signaling pathway affecting neurotransmission and muscle contraction. These pathways involve multiple proteins and cross-talk with other pathways interacting with proteins like estrogen receptors and kinase enzymes.
These targets have significant implications in human health. The Glucocorticoid Receptor is linked to Cushing's syndrome and chronic stress disorders where dysregulation leads to disturbed cortisol production. Androgen Receptor abnormalities are associated with prostate cancer and androgen insensitivity syndrome reflecting disrupted androgen signaling. Maxi Potassium channels interact with proteins like calcium-activated potassium channel blockers and are implicated in hypertension and epilepsy where ion channel dysfunction alters neuronal excitability and blood pressure regulation.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab142856, Clobetasol propionate, Glucocorticoid
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com